EMA Withdrawn: Vitekta (elvitegravir) — Gilead Sciences International Ltd

View source ↗

Summary

EMA withdrawn status for Vitekta (elvitegravir) by Gilead Sciences International Ltd. Indicates withdrawal of the medicinal product in Europe.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Vitekta (elvitegravir)

Snippet

Status: Withdrawn. Therapeutic area: HIV Infections. MAH: Gilead Sciences International Ltd. Decision date: 03/11/2016